Kaitlin Whaley, MD
- Attending Physician, Division of Gastroenterology, Hepatology and Nutrition
- Assistant Professor, UC Department of Pediatrics
- kaitlin.whaley@cchmc.org
- Board Certified
About
Biography
I’m a pediatric gastroenterologist and researcher specializing in inflammatory bowel disease (IBD) and gastrointestinal problems in children with special needs. I enjoy getting to know each patient, not only from a medical perspective but also learning what they enjoy doing at home and school. This holistic approach allows me to help them thrive in their everyday life.
I was inspired to become a physician when I was in grade school, and I haven’t looked back. Working with children was always my goal, and I’m passionate about caring for kids who have gastrointestinal conditions.
In my research, I focus on improving the quality of care for children with gastrointestinal illnesses, especially IBD.
When I’m not helping patients, I enjoy spending time with my family, playing tennis, reading and traveling.
MD: University of Louisville School of Medicine, Louisville, KY.
Pediatric Residency: Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL.
Fellowship: Pediatric Gastroenterology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Interests
Pediatric gastroenterology; Inflammatory Bowel Disease (IBD); GI disorders for children with special needs
Services and Specialties
Gastroenterology
Interests
Quality improvement; pediatric IBD
Locations (3)
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
Precision Dosing of Anti-TNF Therapy in Pediatric Inflammatory Bowel Disease. Current Gastroenterology Reports. 2023; 25:323-332.
Racial Disparities in Pediatric Inflammatory Bowel Disease Care: Differences in Outcomes and Health Service Utilization Between Black and White Children. The Journal of Pediatrics. 2023; 260:113522.
Su1013 EVALUATION OF INSURANCE TYPE ON PRIOR AUTHORIZATION (PA) DELAYS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS PRESCRIBED BIOLOGIC THERAPIES. Gastroenterology. 2023; 164:s-504-s-505.
Multicenter Cohort Study of Infliximab Pharmacokinetics and Therapy Response in Pediatric Acute Severe Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 2023; 21:1338-1347.
714 INFLIXIMAB CLEARANCE IN RELATION TO DISEASE ACTIVITY DURING INDUCTION AND MAINTENANCE THERAPY OF ACUTE SEVERE AND AMBULATORY PEDIATRIC ULCERATIVE COLITIS. Gastroenterology. 2023; 164:s-150.
Vedolizumab Experience in Children and Adolescents With Inflammatory Bowel Disease: A Multicenter Observational Study. Crohn's && Colitis 360. 2021; 3:otab039.
727 ANTI-TNF PHARMACOKINETICS AND RESPONSE TO THERAPY IN PEDIATRIC ACUTE SEVERE ULCERATIVE COLITIS (THE ARCH STUDY). Gastroenterology. 2021; 160:s-145.
ANTI-TNF PHARMACOKINETICS AND RESPONSE TO THERAPY IN PEDIATRIC ACUTE SEVERE ULCERATIVE COLITIS (THE ARCH STUDY). Gastroenterology. 2021; 160:s75-s76.
ANTI-TNF PHARMACOKINETICS AND RESPONSE TO THERAPY IN PEDIATRIC ACUTE SEVERE ULCERATIVE COLITIS (THE ARCH STUDY). Inflammatory Bowel Diseases. 2021; 27:s55-s56.
Expanding and Underscoring the Hepato-Encephalopathic Phenotype of QIL1/MIC13. Hepatology. 2019; 70:1066-1070.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2024 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey